Braden Bohrmann - Profile and Investment Details

Investor Profile

Braden Bohrmann is a Venture Capital based in Portland, Maine, United States with a diverse investment portfolio that includes companies such as Vantia Therapeutics, Spherics, Onbone, Zipline Medical, Solx, Oxxon Therapeutics, Horizon Discovery, Clavis Pharma, Tarsa Therapeutics, GT Medical Technologies, Cara Therapeutics, SkyCell, Heptares Therapeutics, Providence Medical Technology, Vertos MedicalSerentis, Cheetah Medical, Biotheranostics, BioVex, De Novo Pharmaceuticals, Patient Connect, BioXell, Wilson Therapeutics, eXmoor Pharma, PregLem, Aegerion Pharmaceuticals, AmbioPharm, Lombard Medical plc, Momenta Pharmaceuticals, Evotec Neurosciences, VitalConnect, Avantium Technologies, Xention, Paragon 28, eZono, Beacon Endoscopic, Vascular Pathways, MDxHealth, AccuVein, . Over time, Braden Bohrmann has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Braden Bohrmann is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Women Founded, Life Science, Analytics, Biotechnology, Hardware, Logistics, Health Diagnostics, Developer Tools, Medical, Information Technology, Pharmaceuticals may find it worthwhile to explore potential connections with Braden Bohrmann, as their portfolio suggests a familiarity and interest in this area.

Understanding Braden Bohrmann’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.